Cyterix Pharmaceuticals is a cancer therapeutics company developing small molecule prodrugs.
Business Model:
Revenue: $14.2M
Employees: 51-200
Address: 1700 Owens Street Suite 500
City: San Francisco
State: CA
Zip: 94158
Country: US
Cyterix Pharmaceuticals, Inc., a privately held cancer therapeutics company, is engaged in the discovery and development of new classes of small molecule prodrugs with improved safety and efficacy over traditional drugs. The company&s;s approach, based on a proprietary technology platform, uniquely enables the design of multiple classes of anticancer prodrugs that are selectively activated by extra-hepatic cytochrome P450 enzymes that are greatly over-expressed in a broad range of solid tumor and hematologic cancers, but not in normal tissues.
Contact Phone:
+14158652059
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2011 | Series A | 2 | $9.2M |
SV Health Investors The Column Group SV Health Investors The Column Group |
7/2012 | Venture Round | 1 | $7.3M |
SV Health Investors SV Health Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|